• Larner Representatives Attend Medical Education Millennium Conference
    May 24, 2023
    The Larner College of Medicine was one of eight medical schools selected to participate in the 2023 Millennium Conference from May 2-4, hosted by the Carl J. Shapiro Institute for Education and Research at Harvard Medical School and Beth Israel Deaconess Medical Center. Five Larner representatives attended the event, which focused on professionalism for physicians.
  • Postdoctoral Research Showcased at UVM Event
    May 18, 2023
    Promising young scientists from colleges across the UVM campus gathered recently to celebrate the broad training experience, varied investigations, and collaborative community of UVM’s postdoctoral scholars. Organized by the UVM Postdoctoral Association, the event provided a chance for the scholars to present their research and network with peers.
  • Medical Students, Faculty, & Staff Recognized at Class of ’23 Honors Night
    May 17, 2023
    The Larner College of Medicine medical Class of 2023 Honors Night on May 15 featured recognition and awards for graduating medical students, faculty, and staff.
  • Dixon Quoted in NBC5 Story on Recruitment of Millennials for Long-Term Nationwide Lung Health Cohort Study
    May 17, 2023
    (MAY 17, 2023) NBC5 featured pulmonologist Anne Dixon, M.A., B.M.B.Ch., professor of medicine, in a story about recruiting millennials for a long-term nationwide Lung Health Cohort Study. The pioneering study will follow 4,000 young, healthy adults to paint a clearer picture of lung health and the factors involved in predicting and preventing lung disease.
  • Invention to Venture: Larner Creators Bring Medical Innovations to Marketplace
    May 11, 2023
    The Larner College of Medicine has been at the vanguard of technology transfer over the past decade, supporting patents and commercialization of faculty research, which has led to several successful startups. Recent examples of commercially successful innovations by Larner faculty include Prolocor, a startup company focused on developing a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.